Q-VANT Biosciences Achieves GMP Certification for Commercial-Scale QS-21 Production NewsPress Q-VANT Biosciences Achieves GMP Certification for Commercial-Scale QS-21 Production
Q-VANT and SPI Pharma Offering Broader Access to Sustainable and Scalable Pharma-grade Saponin Adjuvants Press Q-VANT and SPI Pharma Offering Broader Access to Sustainable and Scalable Pharma-grade Saponin Adjuvants
Q-VANT Biosciences Launches to Solve the Pharmaceutical Industry Problem of Limited Quillaja Saponin Adjuvants for Life-Saving Vaccines Press Q-VANT Biosciences Launches to Solve the Pharmaceutical Industry Problem of Limited Quillaja Saponin Adjuvants for Life-Saving Vaccines
